APA (7th ed.) Citation

EP, J., DR, P., JD, D., B, H., SY, C., & IF, P. (2013). YM-155 potentiates the effect of ABT-737 in malignant human glioma cells via survivin and Mcl-1 downregulation in an EGFR-dependent context. Molecular cancer therapeutics, 12(3), 326. https://doi.org/10.1158/1535-7163.MCT-12-0901

Chicago Style (17th ed.) Citation

EP, Jane, Premkumar DR, DiDomenico JD, Hu B, Cheng SY, and Pollack IF. "YM-155 Potentiates the Effect of ABT-737 in Malignant Human Glioma Cells via Survivin and Mcl-1 Downregulation in an EGFR-dependent Context." Molecular Cancer Therapeutics 12, no. 3 (2013): 326. https://doi.org/10.1158/1535-7163.MCT-12-0901.

MLA (9th ed.) Citation

EP, Jane, et al. "YM-155 Potentiates the Effect of ABT-737 in Malignant Human Glioma Cells via Survivin and Mcl-1 Downregulation in an EGFR-dependent Context." Molecular Cancer Therapeutics, vol. 12, no. 3, 2013, p. 326, https://doi.org/10.1158/1535-7163.MCT-12-0901.